Brief: Kuros Biosciences Says H1 Revenue CHF 10.4 Mln

Kuros Biosciences AG

09/08/2022 16:55

Aug 9 (Reuters) - Kuros Biosciences AG  KURN.S :
    * KUROS BIOSCIENCES REPORTS RESULTS FOR THE FIRST SIX MONTHS
OF
2022
    * H1 PRODUCT SALES INCREASED BY 58% TO CHF 5.7 MILLION
    * H1 REVENUE CHF 10.4 MILLION
    * NET LOSS FOR FIRST HALF OF 2022 AMOUNTED TO CHF 3.7
MILLION,
COMPARED TO CHF 0.1 MILLION FOR FIRST HALF OF 2021

Source text for Eikon:  ID:nEQ7NT7kca 
Further company coverage:  KURN.S 

 ((Reuters.Briefs@thomsonreuters.com;))